Literature DB >> 25801769

Role for NOD2 in Mycobacterium tuberculosis-induced iNOS expression and NO production in human macrophages.

Michelle B Landes1, Murugesan V S Rajaram1, Huy Nguyen1, Larry S Schlesinger2.   

Abstract

M.tb, which causes TB, is a host-adapted intracellular pathogen of macrophages. Macrophage intracellular PRRs, such as NOD proteins, regulate proinflammatory cytokine production in response to various pathogenic organisms. We demonstrated previously that NOD2 plays an important role in controlling the inflammatory response and viability of M.tb and Mycobacterium bovis BCG in human macrophages. Various inflammatory mediators, such as cytokines, ROS, and RNS, such as NO, can mediate this control. iNOS (or NOS2) is a key enzyme for NO production and M.tb control during infection of mouse macrophages; however, the role of NO during infection of human macrophages remains unclear, in part, as a result of the low amounts of NO produced in these cells. Here, we tested the hypothesis that activation of NOD2 by its ligands (MDP and GMDP, the latter from M.tb) plays an important role in the expression and activity of iNOS and NO production in human macrophages. We demonstrate that M.tb or M. bovis BCG infection enhances iNOS expression in human macrophages. The M.tb-induced iNOS expression and NO production are dependent on NOD2 expression during M.tb infection. Finally, NF-κB activation is required for NOD2-dependent expression of iNOS in human macrophages. Our data provide evidence for a new molecular pathway that links activation of NOD2, an important intracellular PRR, and iNOS expression and activity during M.tb infection of human macrophages. © Society for Leukocyte Biology.

Entities:  

Keywords:  NF-κB; NLR; nitric oxide

Mesh:

Substances:

Year:  2015        PMID: 25801769      PMCID: PMC4438743          DOI: 10.1189/jlb.3A1114-557R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  54 in total

1.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

2.  Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease.

Authors:  H Kimura; S Miura; T Shigematsu; N Ohkubo; Y Tsuzuki; I Kurose; H Higuchi; Y Akiba; R Hokari; M Hirokawa; H Serizawa; H Ishii
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

3.  Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate.

Authors:  M L Cameron; D L Granger; J B Weinberg; W J Kozumbo; H S Koren
Journal:  Am Rev Respir Dis       Date:  1990-12

4.  Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses.

Authors:  Murugesan V S Rajaram; Michelle N Brooks; Jessica D Morris; Jordi B Torrelles; Abul K Azad; Larry S Schlesinger
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

5.  A fluorometric assay for the measurement of nitrite in biological samples.

Authors:  T P Misko; R J Schilling; D Salvemini; W M Moore; M G Currie
Journal:  Anal Biochem       Date:  1993-10       Impact factor: 3.365

6.  Neutrophil-mediated nitrosamine formation: role of nitric oxide in rats.

Authors:  M B Grisham; K Ware; H E Gilleland; L B Gilleland; C L Abell; T Yamada
Journal:  Gastroenterology       Date:  1992-10       Impact factor: 22.682

7.  Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.

Authors:  Naohiro Inohara; Yasunori Ogura; Ana Fontalba; Olga Gutierrez; Fernando Pons; Javier Crespo; Koichi Fukase; Seiichi Inamura; Shoichi Kusumoto; Masahito Hashimoto; Simon J Foster; Anthony P Moran; Jose L Fernandez-Luna; Gabriel Nuñez
Journal:  J Biol Chem       Date:  2003-01-04       Impact factor: 5.157

8.  Endothelial nitric oxide synthase is expressed in cultured human bronchiolar epithelium.

Authors:  P W Shaul; A J North; L C Wu; L B Wells; T S Brannon; K S Lau; T Michel; L R Margraf; R A Star
Journal:  J Clin Invest       Date:  1994-12       Impact factor: 14.808

9.  A novel antioxidant gene from Mycobacterium tuberculosis.

Authors:  S Ehrt; M U Shiloh; J Ruan; M Choi; S Gunzburg; C Nathan; Q Xie; L W Riley
Journal:  J Exp Med       Date:  1997-12-01       Impact factor: 14.307

10.  Increased NOD2-mediated recognition of N-glycolyl muramyl dipeptide.

Authors:  François Coulombe; Maziar Divangahi; Frédéric Veyrier; Louis de Léséleuc; James L Gleason; Yibin Yang; Michelle A Kelliher; Amit K Pandey; Christopher M Sassetti; Michael B Reed; Marcel A Behr
Journal:  J Exp Med       Date:  2009-07-06       Impact factor: 14.307

View more
  13 in total

Review 1.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

2.  Ac2PIM-responsive miR-150 and miR-143 target receptor-interacting protein kinase 2 and transforming growth factor beta-activated kinase 1 to suppress NOD2-induced immunomodulators.

Authors:  Praveen Prakhar; Sahana Holla; Devram Sampat Ghorpade; Martine Gilleron; Germain Puzo; Vibha Udupa; Kithiganahalli Narayanaswamy Balaji
Journal:  J Biol Chem       Date:  2015-09-21       Impact factor: 5.157

3.  Guanine nucleotide exchange factor -H1 promotes inflammatory cytokine production and intracellular mycobacterial elimination in macrophages.

Authors:  Hui Wang; Jinli Wang; Jiahui Yang; Xiaofan Yang; Jianchun He; Ruining Wang; Sudong Liu; Lin Zhou; Li Ma
Journal:  Cell Cycle       Date:  2017-08-07       Impact factor: 4.534

Review 4.  Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration.

Authors:  Joseph E Qualls; Peter J Murray
Journal:  Semin Immunopathol       Date:  2015-10-21       Impact factor: 9.623

5.  The influence of single nucleotide polymorphisms of NOD2 or CD14 on the risk of Mycobacterium tuberculosis diseases: a systematic review.

Authors:  Juan M Cubillos-Angulo; Catarina D Fernandes; Davi N Araújo; Cristinna A Carmo; María B Arriaga; Bruno B Andrade
Journal:  Syst Rev       Date:  2021-06-09

6.  Mutual alteration of NOD2-associated Blau syndrome and IFNγR1 deficiency.

Authors:  Zuzana Parackova; Marketa Bloomfield; Petra Vrabcova; Irena Zentsova; Adam Klocperk; Tomas Milota; Michael Svaton; Jean-Laurent Casanova; Jacinta Bustamante; Eva Fronkova; Anna Sediva
Journal:  J Clin Immunol       Date:  2019-11-23       Impact factor: 8.542

7.  An In Vitro Co-culture Mouse Model Demonstrates Efficient Vaccine-Mediated Control of Francisella tularensis SCHU S4 and Identifies Nitric Oxide as a Predictor of Efficacy.

Authors:  Igor Golovliov; Helena Lindgren; Kjell Eneslätt; Wayne Conlan; Amandine Mosnier; Thomas Henry; Anders Sjöstedt
Journal:  Front Cell Infect Microbiol       Date:  2016-11-25       Impact factor: 5.293

8.  Mononuclear-macrophages but not neutrophils act as major infiltrating anti-leptospiral phagocytes during leptospirosis.

Authors:  Xu Chen; Shi-Jun Li; David M Ojcius; Ai-Hua Sun; Wei-Lin Hu; Xu'ai Lin; Jie Yan
Journal:  PLoS One       Date:  2017-07-11       Impact factor: 3.240

9.  Nucleotide-Binding Oligomerization Domain 2 Contributes to Limiting Growth of Mycobacterium abscessus in the Lung of Mice by Regulating Cytokines and Nitric Oxide Production.

Authors:  Jun-Young Lee; Moo-Seung Lee; Dong-Jae Kim; Soo-Jin Yang; Sang-Jin Lee; Eui-Jeong Noh; Sung Jae Shin; Jong-Hwan Park
Journal:  Front Immunol       Date:  2017-11-06       Impact factor: 7.561

Review 10.  Underwhelming or Misunderstood? Genetic Variability of Pattern Recognition Receptors in Immune Responses and Resistance to Mycobacterium tuberculosis.

Authors:  Jean-Yves Dubé; Vinicius M Fava; Erwin Schurr; Marcel A Behr
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.